Papoian, Thomas <br/><br/>
Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective.  [electronic resource] 

 -  Nature reviews. Drug discovery  Apr 2015 
 - 294 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1474-1784 
<br/><br/><label>Standard No.: </label>10.1038/nrd3845-c1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cost-Benefit Analysis<br/>Drug-Related Side Effects and Adverse Reactions<br/>Humans<br/>Legislation, Drug--trends<br/>Off-Label Use<br/>Pharmacology, Clinical--trends<br/>Structure-Activity Relationship